Linden Thomas Advisory Services’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$781K Buy
1,547
+40
+3% +$20.7K 0.06% 370
2026
Q2
$702K Sell
1,507
-2,658
-64% -$1.12M 0.06% 384
2026
Q1
$1.57M Sell
4,165
-2,781
-40% -$1.19M 0.15% 237
2025
Q4
$2.97M Sell
6,946
-406
-6% -$177K 0.3% 88
2025
Q3
$3.29M Sell
7,352
-47
-0.6% -$21.3K 0.33% 77
2025
Q2
$3.6M Sell
7,399
-106
-1% -$60.4K 0.4% 68
2025
Q1
$4.62M Sell
7,505
-9
-0.1% -$5.12K 0.6% 24
2024
Q4
$3.98M Sell
7,514
-58
-0.8% -$32.7K 0.5% 30
2024
Q3
$4.55M Sell
7,572
-24
-0.3% -$13.6K 0.62% 16
2024
Q2
$4.12M Buy
7,596
+589
+8% +$337K 0.64% 13
2024
Q1
$4.5M Sell
7,007
-10
-0.1% -$6.08K 0.72% 8
2023
Q4
$4.1M Buy
7,017
+57
+0.8% +$31.9K 0.77% 7
2023
Q3
$3.62M Sell
6,960
-527
-7% -$274K 0.81% 4
2023
Q2
$4.06M Buy
7,487
+101
+1% +$55.2K 0.9% 8
2023
Q1
$3.97M Buy
7,386
+311
+4% +$159K 0.99% 4
2022
Q4
$3.61M Buy
+7,075
New +$3.44M 1.02% 4

Other funds holding CHE

Linden Thomas Advisory Services's CHE Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Chemed (CHE) stake by 2.7% in Q3 2026, buying an estimated $20.7K and bringing the position to 1,547 shares worth $781K. The position accounts for 0.06% of the portfolio, ranked #370.

Linden Thomas Advisory Services first reported a position in CHE in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.62M in Q1 2025. 376 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Linden Thomas Advisory Services held 1,547 shares of Chemed worth $781K as of Q3 2026.
  • Linden Thomas Advisory Services bought 40 Chemed shares in Q3 2026, an estimated $20.7K.
  • Chemed made up 0.06% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #370 holding.
  • Linden Thomas Advisory Services first reported a position in Chemed in Q4 2022 and has held it in 16 quarters since.
  • Linden Thomas Advisory Services's Chemed position peaked at $4.62M in Q1 2025.
  • 376 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.